KD Logo

Investing in Boston Scientific Corp. (BSX) Is Getting More Attractive

In a filing, Boston Scientific Corp. revealed its Chairman, President & CEO Mahoney Michael F unloaded Company’s shares for reported $13.78 million on Oct 07 ’24. In the deal valued at $84.63 per share,162,777 shares were sold. As a result of this transaction, Mahoney Michael F now holds 1,572,096 shares worth roughly $138.42 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Fitzgerald Joseph Michael sold 132,527 shares, generating $11,264,888 in total proceeds. Upon selling the shares at $85.00, the EVP & Group Pres, Cardiology now owns 160,467 shares.

Before that, JOSEPH M FITZGERALD bought 132,527 shares. Boston Scientific Corp. shares valued at $11,264,890 were divested by the Officer at a price of $85.00 per share.

Needham downgraded its Boston Scientific Corp. [BSX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Mizuho also remained covering BSX and has increased its forecast on February 01, 2024 with a “Buy” recommendation from previously “Neutral” rating. Robert W. Baird started covering the stock on July 19, 2023. It rated BSX as “an Outperform”.

Price Performance Review of BSX

On Monday, Boston Scientific Corp. [NYSE:BSX] saw its stock fall -0.02% to $88.05. Over the last five days, the stock has gained 0.57%. Boston Scientific Corp. shares have risen nearly 52.31% since the year began. Nevertheless, the stocks have risen 74.18% over the past one year. While a 52-week high of $88.71 was reached on 10/21/24, a 52-week low of $49.15 was recorded on 01/02/24. SMA at 50 days reached $82.61, while 200 days put it at $73.48.

Levels Of Support And Resistance For BSX Stock

The 24-hour chart illustrates a support level at 87.68, which if violated will result in even more drops to 87.31. On the upside, there is a resistance level at 88.61. A further resistance level may holdings at 89.16. The Relative Strength Index (RSI) on the 14-day chart is 69.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.30, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.14%. Stochastics %K at 81.03% indicates the stock is a selling.

How much short interest is there in Boston Scientific Corp.?

A steep rise in short interest was recorded in Boston Scientific Corp. stocks on 2024-09-30, dropping by -0.1 million shares to a total of 10.92 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 11.02 million shares. There was a decline of -0.94%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on June 30, 2023 when CL King began covering the stock and recommended ‘”a Buy”‘ rating along with a $64 price target.

Most Popular